A Prospective, Double Blind, Randomized, Placebo-controlled Trial of Antroquinonol in Patients With Hypercholesterolemia and Hyperlipidemia
Phase of Trial: Phase II
Latest Information Update: 23 Mar 2017
At a glance
- Drugs Antroquinonol (Primary)
- Indications Hypercholesterolaemia; Hyperlipidaemia
- Focus Therapeutic Use
- Sponsors Golden Biotechnology Corporation
- 19 Mar 2017 Planned End Date changed from 1 Jan 2017 to 1 Feb 2018.
- 19 Mar 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Dec 2017.
- 17 May 2016 Status changed from not yet recruiting to recruiting.